PONIARD PHARMACEUTICALS, INC.
CIK 0000755806
Revenue (TTM)
—
Q3 Oct 2011
Net Income (TTM)
−$20.62M
Q3 Oct 2011
EPS Diluted (TTM)
—
Q3 Oct 2011
Gross Margin
—
Q3 Oct 2011
Operating Margin
—
Q3 Oct 2011
Net Margin
—
Q3 Oct 2011
Free Cash Flow (TTM)
—
Q3 Oct 2011
Cash
$1.98M
Q3 Oct 2011
Total Debt
—
Q3 Oct 2011
Shares Outstanding
59.97M sh
Q3 Oct 2011